Bloomberg: “Former Chicago trader battles medical science giants over gene therapy deal”

(Bloomberg) — Patrick Girondi, a former commodities trader from Chicago, lives in Italy these days. But for the last couple of years, he’s been spending weeks at a time crashing at a friend’s apartment in Manhattan, waging a bare-knuckle and uphill legal battle against two well-regarded names in medical science: Bluebird Bio, a cutting edge gene-therapy company, and Sloan Kettering Institute, the research arm of the famous cancer center.

View the rest of the article here

View the PDF